ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 307

Risk Factors for Poor Outcomes in Hospitalized Patients with Pediatric Systemic Lupus Erythematosus

Mary Beth F. Son1, Victor M. Johnson2, Mindy S. Lo3 and Karen H. Costenbader4, 1Division of Rheumatology and Immunology, University Children's Medical Institute, Singapore, Singapore, 2Department of Anesthesiology, Perioperative and Pain Medicine, Children's Hospital Boston, Boston, MA, 3Division of Immunology, Boston Children's Hospital, Boston, MA, 4Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: death, Outcome measures, Pediatric rheumatology, renal disease and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Disparities in care among adults with SLE are well documented.  We investigated associations of demographic factors and volume of annual inpatient hospital admissions with poor outcomes, including intensive care unit admission, renal failure and in-hospital mortality, among hospitalized patients with pediatric SLE.  

Methods: The Pediatric Health Information System (PHIS) is an administrative database contributed to by >40 freestanding U.S. pediatric hospitals.  We queried PHIS regarding all discharges for patients aged 3-21 years with at least one ICD-9 code for SLE from Jan 2006-Sept 2011. Patient demographics, medical insurance, hospital and ICU admissions, lengths of stay, renal failure (based on ICD-9 coding), and deaths were recorded. We classified hospitals according to the volume of inpatient admissions per year, in quartiles.  We used summary statistics and univariable analyses to examine demographics of hospital admissions, readmissions, and lengths of stay. We employed multivariable logistic regression analyses, controlling for patient age, sex, race, ethnicity, insurance type (private, governmental, self-pay, or none), U.S. region (Northeast, South, Midwest and West), and hospital volume to examine risk factors for adverse outcomes, including ICU admission, renal failure and in-hospital mortality. 

Results: A total of 3,389 patients with 14,631 admissions were identified in the study period.  2,781 patients (82%) were female and the median age at the time of the index admission was 16 years (IQR=14–18).  White and African American race each comprised nearly 37% of the patients (n=1,250 and 1,252), while 5% (n=172) were Asian.  Over a quarter of patients (n=888, 26%) were Hispanic or Latino.  87% of patients (n=2,953) had insurance, with over half supported by governmental insurance (n=1876, 55%).  More than a third of patients had renal disease (n=1273, 38%); however, only 0.7% (n=24) had renal failure and 0.2% (n=8) required dialysis therapy.  The high volume hospitals had shorter length of stay as compared to low volume hospitals (median 2 days, IQR=1-5, vs. 3 days, IQR=1-6, p<0.001), although readmissions per patient were more frequent in the higher volume hospitals (median 2, IQR= 1-6, vs. 2, IQR=1-3, p<0.001).  Ten percent of admissions included an ICU stay.  Overall in-hospital mortality was low at 0.4% (n=57).  In multivariable models, ICU stays were associated with age <10 years at first admission (OR=1.61 [1.16 to 2.25], p<0.05).   Poor outcome, defined as renal failure and death, was strongly associated with governmental insurance (OR=2.51 [1.47 to 4.29], p<0.05). 

Conclusion: In our cohort of hospitalized children with SLE, hospital volume affected length of stay and number of readmissions, but not in-hospital mortality.  Governmental insurance in this group of patients was associated with renal failure and in-hospital mortality.  Further studies are needed to understand the relationships of medical insurance type and hospital volume with poor outcomes, in order to address modifiable barriers to care in pediatric SLE.


Disclosure:

M. B. F. Son,
None;

V. M. Johnson,
None;

M. S. Lo,
None;

K. H. Costenbader,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-factors-for-poor-outcomes-in-hospitalized-patients-with-pediatric-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology